Chemed Corp CHE
- Headquarters
- Cincinnati, OH
- CEO
- Kevin J. McNamara
- Next results
- around Feb 24, 2027
Where each dollar of revenue went, FY2025
Revenue of $2.5B through the costs to a net profit of $265.2M · income statement of the 10-K
CHE among Health care peers
Six ratios from the latest 10-K. Each corner is the share of 154 peers the company is above, not a score.
What changed
11 new risk paragraphs. 10-K filed Feb 27, 2026 against Feb 28, 2025.
Each row opens the detail with the quote and the filing. A row is a change worth reading, not a verdict.
Accounting checks
11 checks on the latest 10-K. Checks, not verdicts.
0facts worth reading about all 11 checks found nothing to note
-
Receivables +6.7% ($171.2M to $182.6M) vs revenue +4.1% ($2.4B to $2.5B), +2.6 pts apart
-
Cash from operations $388.3M vs net income $265.2M (FY ending Dec 31, 2025)
-
Inventory -7.9% ($8.2M to $7.5M) vs revenue +4.1% ($2.4B to $2.5B), -12.0 pts apart
8 more checks with nothing to note
-
Same auditor in both 10-Ks: PricewaterhouseCoopers LLP
-
No statement of substantial doubt about going concern
-
No 8-K item 4.02 in the last 2 years
-
No NT 10-K or NT 10-Q in the last 2 years
-
The same matters as last year: VITAS Revenue Implicit Price Concessions
-
No sentence in the 10-K concludes that controls were not effective because of a material weakness
-
No 8-K item 2.06 in the last 2 years
-
No 8-K item 1.03 in the last 2 years
In their words
11 paragraphs in Risk Factors that were not in the 10-K filed Feb 28, 2025. Quoted as filed.
-
Item 1A · new paragraph · not in the 10-K filed Feb 28, 2025 10-K, ITEM 1A
Despite significant safeguards, including active intrusion protection, firewalls and virus detection software, as discussed in greater detail on Item 1C below, in October of 2025, access to our systems was gained by a threat actor in a cybersecurity attack. The threat actor was able to access a significant amount of Protected Health…
-
Item 1A · new paragraph · not in the 10-K filed Feb 28, 2025 10-K, ITEM 1A
While we have been able to mitigate the damages from the prior successful attack, and did not experience any material operational or financial issues as a result of the attack, a subsequent successful attack on our information technology systems could have even greater consequences to the business including liability for compromised…
-
Item 1A · new paragraph · not in the 10-K filed Feb 28, 2025 10-K, ITEM 1A
Significant Tariffs Could Increase Costs, Decrease Margin, and Materially Adversely Affect the Business. Both Roto-Rooter’s and VITAS’s primary businesses are the provision of services within the United States. Accordingly, they are likely to be less affected by the impact of specific or wide-ranging tariffs than many other entities in…
New risk paragraphs, against peers
Latest 10-K of each, Health care companies closest in revenue
Paragraphs in Risk Factors with nothing like them in the company's 10-K the year before. A count of text, not of risk.
Financial performance
Last 4 fiscal years · 10-K XBRL
| Metric | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Revenue | $2.1B | $2.3B | $2.4B | $2.5B |
| Net income | $249.6M | $272.5M | $302.0M | $265.2M |
| Operating cash flow | $309.9M | $330.3M | $417.5M | $388.3M |
| Free cash flow | $252.6M | $273.4M | $368.0M | $325.5M |
Revenue, FY2016 to FY2025
Ten fiscal years, each from its own 10-K · XBRL · USD
$2.5B ▲ 4.1% in FY2025$265.2M ▼ 12.2% in FY2025$325.5M ▼ 11.5% in FY2025
Recent filings
3 filings in the last 30 days · SEC EDGAR
-
Planned saleNov 3, 2026Kevin J McNamara (Officer/Director) gave notice of a planned sale of 2,000 shares worth about $1.1M Form 144, approximate sale date Nov 3, 2026
-
10-QOct 29, 2026Quarterly report (10-Q) period ended Sep 30, 2026
-
8-KOct 27, 2026Quarterly results 8-K item 2.02
About the company
Chemed Corp, Cincinnati, OH · from the 10-K filed Feb 27, 2026
Chemed Corporation (the “Company” or “Chemed”) was incorporated in Delaware in 1970 as a subsidiary of W.R. Grace & Co. and succeeded to the business of W.R. Grace & Co.’s Special Products Group as of April 30, 1971 and remained a subsidiary of W.R. Grace & Co. until March 10, 1982. Chemed purchases, operates and divests subsidiaries engaged in diverse business activities for the purposes of maximizing shareholder value. The Company’s day to day operating businesses are managed on a decentralized basis. There are few integrated business functions between the operating units and Chemed (such as sales, marketing or purchasing).
- Headquarters
- Cincinnati, OH
- Country
- United States
- Reports in
- USD
- Listed on
- NYSE
- Fiscal year ends
- December 31
- Last results
- Oct 27, 2026
- Incorporated in
- DE
Email alerts
Sources
The 10-K filed Feb 27, 2026 (open at SEC), compared with the 10-K filed Feb 28, 2025. Numbers from the XBRL of the 10-Ks; filings from SEC EDGAR.
Work with it: Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/CHE/export.csv") into a cell.